232 related articles for article (PubMed ID: 32039402)
1. Body composition predicts mortality and decompensation in compensated cirrhosis patients: A prospective cohort study.
Tapper EB; Zhang P; Garg R; Nault T; Leary K; Krishnamurthy V; Su GL
JHEP Rep; 2020 Feb; 2(1):100061. PubMed ID: 32039402
[TBL] [Abstract][Full Text] [Related]
2. Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis.
Torp N; Israelsen M; Madsen B; Lutz P; Jansen C; Strassburg C; Mortensen C; Knudsen AW; Sorensen GL; Holmskov U; Schlosser A; Thiele M; Trebicka J; Krag A
JHEP Rep; 2021 Jun; 3(3):100287. PubMed ID: 34041469
[TBL] [Abstract][Full Text] [Related]
3. Liver-to-Spleen Volume Ratio Automatically Measured on CT Predicts Decompensation in Patients with B Viral Compensated Cirrhosis.
Kwon JH; Lee SS; Yoon JS; Suk HI; Sung YS; Kim HS; Lee CM; Kim KM; Lee SJ; Kim SY
Korean J Radiol; 2021 Dec; 22(12):1985-1995. PubMed ID: 34564961
[TBL] [Abstract][Full Text] [Related]
4. Spleen volume-based non-invasive tool for predicting hepatic decompensation in people with compensated cirrhosis (CHESS1701).
Yu Q; Xu C; Li Q; Ding Z; Lv Y; Liu C; Huang Y; Zhou J; Huang S; Xia C; Meng X; Lu C; Li Y; Tang T; Wang Y; Song Y; Qi X; Ye J; Ju S
JHEP Rep; 2022 Nov; 4(11):100575. PubMed ID: 36204707
[TBL] [Abstract][Full Text] [Related]
5. Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis.
Ebadi M; Tandon P; Moctezuma-Velazquez C; Ghosh S; Baracos VE; Mazurak VC; Montano-Loza AJ
J Hepatol; 2018 Sep; 69(3):608-616. PubMed ID: 29709682
[TBL] [Abstract][Full Text] [Related]
6. Adipopenia correlates with higher portal pressure in patients with cirrhosis.
Rodrigues SG; Brabandt B; Stirnimann G; Maurer MH; Berzigotti A
Liver Int; 2019 Sep; 39(9):1672-1681. PubMed ID: 31207018
[TBL] [Abstract][Full Text] [Related]
7. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
8. Anemia and iron deficiency in compensated and decompensated cirrhosis: Prevalence and impact on clinical outcomes.
Paternostro R; Kapzan L; Mandorfer M; Schwarzer R; Benedikt S; Viveiros A; Bauer D; Ferlitsch M; Zoller H; Trauner M; Ferlitsch A
J Gastroenterol Hepatol; 2020 Sep; 35(9):1619-1627. PubMed ID: 31972057
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity.
Krassenburg LAP; Maan R; Ramji A; Manns MP; Cornberg M; Wedemeyer H; de Knegt RJ; Hansen BE; Janssen HLA; de Man RA; Feld JJ; van der Meer AJ
J Hepatol; 2021 May; 74(5):1053-1063. PubMed ID: 33242501
[TBL] [Abstract][Full Text] [Related]
10. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
[TBL] [Abstract][Full Text] [Related]
11. ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related Cirrhosis.
Calzadilla-Bertot L; Vilar-Gomez E; Wong VW; Romero-Gomez M; Aller-de la Fuente R; Wong GL; Castellanos M; Eslam M; Desai AP; Jeffrey GP; George J; Chalasani N; Adams LA
Hepatology; 2021 Jun; 73(6):2238-2250. PubMed ID: 32978796
[TBL] [Abstract][Full Text] [Related]
12. Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis.
Villanueva C; Albillos A; Genescà J; Garcia-Pagan JC; Brujats A; Calleja JL; Aracil C; Bañares R; Morillas RM; Poca M; Peñas B; Augustin S; Abraldes JG; Alvarado E; Torres F; Bosch J;
J Hepatol; 2021 Sep; 75(3):589-599. PubMed ID: 33905794
[TBL] [Abstract][Full Text] [Related]
13. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
[TBL] [Abstract][Full Text] [Related]
14. Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.
Frenette C; Kayali Z; Mena E; Mantry PS; Lucas KJ; Neff G; Rodriguez M; Thuluvath PJ; Weinberg E; Bhandari BR; Robinson J; Wedick N; Chan JL; Hagerty DT; Kowdley KV;
J Hepatol; 2021 Feb; 74(2):274-282. PubMed ID: 33038432
[TBL] [Abstract][Full Text] [Related]
15. Frailty as tested by the Liver Frailty Index is associated with decompensation and unplanned hospitalization in patients with compensated cirrhosis.
Siramolpiwat S; Kiattikunrat K; Soontararatpong R; Pornthisarn B; Vilaichone RK; Chonprasertsuk S; Bhanthumkomol P; Nunanun P; Issariyakulkarn N
Scand J Gastroenterol; 2021 Oct; 56(10):1210-1219. PubMed ID: 34338110
[TBL] [Abstract][Full Text] [Related]
16. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
[TBL] [Abstract][Full Text] [Related]
17. The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis.
Schwarzer R; Reiberger T; Mandorfer M; Kivaranovic D; Hametner S; Hametner S; Paternostro R; Scheiner B; Schneeweiss-Friedl J; Trauner M; Schoefl R; Maieron A
J Gastroenterol; 2020 May; 55(5):533-542. PubMed ID: 31832759
[TBL] [Abstract][Full Text] [Related]
18. Liver Surface Nodularity Score Allows Prediction of Cirrhosis Decompensation and Death.
Smith AD; Zand KA; Florez E; Sirous R; Shlapak D; Souza F; Roda M; Bryan J; Vasanji A; Griswold M; Lirette ST
Radiology; 2017 Jun; 283(3):711-722. PubMed ID: 27809664
[TBL] [Abstract][Full Text] [Related]
19. Dysbalanced sex hormone status is an independent predictor of decompensation and mortality in patients with liver cirrhosis.
Paternostro R; Heinisch BB; Reiberger T; Mandorfer M; Bardach C; Lampichler K; Seeland B; Schwarzer R; Trauner M; Peck-Radosavljevic M; Ferlitsch A
Hepatol Res; 2019 Feb; 49(2):201-211. PubMed ID: 30248213
[TBL] [Abstract][Full Text] [Related]
20. Muscle fat infiltration assessed by total psoas density on computed tomography predicts mortality in cirrhosis.
Kalafateli M; Karatzas A; Tsiaoussis G; Koutroumpakis E; Tselekouni P; Koukias N; Konstantakis C; Assimakopoulos S; Gogos C; Thomopoulos K; Kalogeropoulou C; Triantos C
Ann Gastroenterol; 2018; 31(4):491-498. PubMed ID: 29991895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
